Recombinant BAFF (Belimumab Biosimilar) antibody

Catalog No. ABIN7093063

The Human Monoclonal anti-BAFF (Belimumab Biosimilar) antibody has been validated for ELISA. It is suitable to detect BAFF (Belimumab Biosimilar) in samples from Human.

Quick Overview for Recombinant BAFF (Belimumab Biosimilar) antibody (ABIN7093063)

Target: BAFF (Belimumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Human

Clonality: Monoclonal

Application: ELISA

Grade: Research Grade

Product Details anti-BAFF (Belimumab Biosimilar) Antibody

Purpose: Anti-BAFF (belimumab biosimilar) mAb

Characteristics: LymphoStat-B, hBlySmAb-1.1

Purification: Purified from cell culture supernatant by affinity chromatography

Isotype: IgG1

Application Details

Application Notes: ELISA 1:5000-10000

Comment:

Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.

Restrictions: For Research Use only

Handling

Format: Lyophilized

Reconstitution: Reconstitute with deionized water

Buffer: Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8 % trehalose is added as protectants before lyophilization.

Storage: -20 °C,-80 °C

Storage Comment: Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature.

Expiry Date: 12 months

Target Details for BAFF (Belimumab Biosimilar)

Target: BAFF (Belimumab Biosimilar)

Target Type: Biosimilar

Background: Synonyms: TNFSF13B,BAFF,BLYS,CD257,DTL,TALL1,THANK,TNFSF20,ZTNF4,TALL-1

Gene ID: 10673

UniProt: Q9Y275